Fidelity Investments’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 5010 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4397 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 4317 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4028 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | – | – | 3710 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3644 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 3661 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3580 |
|